Working… Menu
Trial record 1 of 11 for:    Cavernous Malformation, Cerebral
Previous Study | Return to List | Next Study

Treat_CCM: Propranolol in Familial Cerebral Cavernous Malformation (Treat_CCM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03589014
Recruitment Status : Active, not recruiting
First Posted : July 17, 2018
Last Update Posted : April 14, 2021
IFOM, The FIRC Institute of Molecular Oncology
Information provided by (Responsible Party):
Mario Negri Institute for Pharmacological Research

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 31, 2021
Estimated Study Completion Date : December 31, 2021

Publications automatically indexed to this study by Identifier (NCT Number):